新型溶栓药物瑞替普酶

A NEW THROMBOLYTIC DRUG RETEPLASE

瑞替普酶是人类组织型纤溶酶原激活物的一部份，在大肠杆菌中合成。与其他溶栓药物相比，瑞替普酶具有疗效显著，起效迅速，使用方便，不良反应小等优点。

Reteplase is a part of human tissue type plasminogen. It is expressed in Escherichia Coli cells.It possesses the advantages of significant efficacy,rapid in response and less ADRs in comparison with other thrombolytics.